Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma
NCT00934440Phase 2Terminated
- Sponsor
- University of Kansas Medical Center
- Start
- Jun 2009
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azacitidine in renal cell carcinoma (RCC), sponsored by University of Kansas Medical Center. Started Jun 2009; status: terminated.
02
Drugs
azacitidine
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00934440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00934440.